Laura Gonzalez-Estefani
Founder, CEO & General Partner @ TheVentureCity
Menlo Park, United States
Laura Gonzalez-Estefani is a seed investor at TheVentureCity in Menlo Park focused on Health Care and Information Technology. Laura Gonzalez-Estefani is based out of Miami, Florida and is the Founder & CEO, General Partner of the Fund of TheVentureCity. Laura previously worked at European Commission as a European Innovation Council Fund, Member of the Investment Commitee. Laura Gonzalez-Estefani attended the European University.
- Total investments:
- 21
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Laura Gonzalez-Estefani invests in
Stages Laura Gonzalez-Estefani invests in
Countries Laura Gonzalez-Estefani invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $114k–$4.5M
- Pre-Seed
- $400k–$2.5M
- Series A
- $3M–$8.7M
Investment Focus
Industry
- Health Care 4 (19%)
- Information Technology 4 (19%)
- Software 3 (14%)
- Artificial Intelligence 3 (14%)
- Apps 2 (10%)
Stage
- Seed 6 (29%)
- Series A 5 (24%)
- Pre-Seed 4 (19%)
- Grant 1 (5%)
- Series B 1 (5%)
Country
- United States 5 (24%)
- Spain 4 (19%)
- Chile 1 (5%)
- Brazil 1 (5%)
- Sweden 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $33M / Series B / Sep 29, 2026 | ||
| Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $8.5M / Series A / Mar 05, 2024 | ||
| Forest is a dockless, shared, and ad-supported e-bike service company. | $8.7M / Series A / Apr 27, 2023 | ||
| BrandLovrs provides a one-of-a-kind model for gamifying influencer marketing campaigns Brands may use the BrandLovrs platform to collaborate with a large number of producers for scalable and gamified influencer marketing. | Seed / Apr 19, 2023 | ||
| BrandLovrs provides a one-of-a-kind model for gamifying influencer marketing campaigns Brands may use the BrandLovrs platform to collaborate with a large number of producers for scalable and gamified influencer marketing. | $2M / Pre-Seed / Apr 19, 2023 | ||
| Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $4.5M / Seed / Nov 02, 2022 | ||
| Plexigrid develops software that provides tailored solutions for electrical systems by using data analysis. | $2.3M / Seed / Feb 01, 2022 | ||
| OneProjects is an Irish-German cardiac imaging specialist. | $3M / Grant / Oct 14, 2021 | ||
| OneProjects is an Irish-German cardiac imaging specialist. | $8M / Series A / Oct 14, 2021 | ||
| Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management. | $3.8M / Convertible Note / Oct 05, 2021 | ||
| See all 21 investments → | |||
Co-Investors
About TheVentureCity
TheVentureCity is an early-stage venture capital fund working alongside tech founders redefining fundamental industries. Managing over $150M, the fund leads Seed and Series A rounds of $2.5M to $4M across the United States, Europe and Latin America. We invest in companies across fintech, healthtech and mobility & logistics, where proprietary data, AI and automation are core to building defensible products.
TheVentureCity Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ana Olivan Lopez
Director Of Operations
|
|||
Andres Dancausa
General Partner, Fund
|
|||
Carlos Montes González
VP, Comms. & People EMEA
|
|||
Clara Bullrich
Co-Founder & General Partner
|
|||
Ricardo Sangion
Partner - Americas
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Laura Gonzalez-Estefani invest in?
Laura Gonzalez-Estefani invests primarily in Health Care, Information Technology and Software startups, most often at Seed and Series A stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Laura Gonzalez-Estefani invest in?
Laura Gonzalez-Estefani typically joins rounds of $114k–$4.5M at Seed, $400k–$2.5M at Pre-Seed and $3M–$8.7M at Series A. These are whole funding-round sizes, not Laura Gonzalez-Estefani's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Laura Gonzalez-Estefani took part in.
How do I contact Laura Gonzalez-Estefani?
Public channels for Laura Gonzalez-Estefani include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Laura Gonzalez-Estefani last invest?
The most recent investment recorded for Laura Gonzalez-Estefani closed in Sep 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
